Catalent | CTLT - DEBITO



DEBITO Cambiamento Data
Agilent USD 3.36B 1000K 2026-03
AstraZeneca USD 32.24B 1.68B 2026-06
Bristol-Myers Squibb USD 46.43B 711M 2026-03
Bruker USD 1.82B 153.5M 2026-06
Centene USD 16.1B 266M 2026-06
Charles River Laboratories USD 3.06B 485.84M 2026-03
Cigna USD 30.9B 563M 2026-03
Danaher USD 26.56B 8.07B 2026-06
Dentsply International USD 2.33B 137M 2026-03
Elevance Health USD 31.04B 798M 2026-06
Eli Lilly USD 43.37B 867M 2026-03
Glaxosmithkline GBP 19.06B 1.31B 2026-03
Humana USD 14.25B 254M 2026-06
Illumina USD 2.54B 9M 2026-03
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 16.24B 408M 2026-06
J&J USD 54.99B 7.05B 2026-03
Laboratory Of America USD 7.24B 714.6M 2026-03
Lonza CHF 4.71B 915M 2024-12
McKesson USD 8.61B 10M 2026-03
Merck EUR 12.04B 86M 2026-03
Merck USD 49.12B 222M 2026-03
Mettler Toledo International USD 2.23B 76.47M 2026-03
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 63.19B 536M 2026-06
Quest Diagnostics USD 6.41B 179M 2026-03
Repligen USD 690.94M 144.36M 2026-06
Revvity USD 3.35B 48.03M 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Supernus Pharmaceuticals USD 40.17M 733K 2026-06
Thermo Fisher Scientific USD 43.16B 3.78B 2026-03
UnitedHealth USD 73.33B 4.59B 2026-06
Veradigm USD 200.33M 431K 2022-09
Waters USD 5.57B 4.08B 2026-03
West Pharmaceutical Services USD 202.8M 0 2026-03